Aripiprazole (Abilify) Withdrawal Symptoms and Management

Naomi Carr
Hailey Okamoto
Written by Naomi Carr on 04 March 2026
Medically reviewed by Hailey Okamoto on 08 March 2026

Aripiprazole (Abilify) is an antipsychotic medication often used in the treatment of various mental health conditions, particularly psychotic disorders. Aripiprazole withdrawal symptoms can occur when the medication is stopped, especially if it is stopped suddenly. Stopping aripiprazole requires professional guidance and management of withdrawal symptoms.

Key takeaways:
  • Aripiprazole (Abilify) can cause withdrawal symptoms when it is stopped suddenly, especially after long-term use.
  • People should not stop taking aripiprazole without professional advice, as there is a risk of severe withdrawal symptoms and relapse of mental health symptoms.
  • Aripiprazole cessation should only be done with professional advice. Physicians can help manage withdrawal symptoms that occur, often by adding another medication or gradually reducing the dose.
A photo of a Caucasian man in front of his laptop but is unable to concentrate and feeling irritable due to aripiprazole withdrawal

Can aripiprazole (Abilify) cause withdrawal symptoms?

Cessation of aripiprazole (Abilify) can cause withdrawal symptoms, particularly if the medication is stopped abruptly.

Aripiprazole (Abilify) is an antipsychotic medication, most commonly used to treat schizophrenia, and also sometimes used in the treatment of bipolar disorder mania, major depressive disorder, autism spectrum disorder (ASD), and Tourette’s syndrome.

Sometimes, people requiring aripiprazole to manage mental health symptoms will need to remain on medication long-term. For example, schizophrenia is a chronic condition that typically requires long-term maintenance treatment. However, aripiprazole can also be used short-term to manage acute symptoms, such as in ASD or bipolar disorder.

Aripiprazole treatment will sometimes need to be stopped when treatment is no longer required. It might also be stopped if there are unmanageable side effects or contraindications, or when switching medications. When aripiprazole treatment is stopped, withdrawal symptoms can emerge. This is more likely if treatment has been ongoing for several months or years and if it is stopped suddenly.

Because aripiprazole is used in the treatment of severe mental health conditions, it can be difficult to differentiate between withdrawal symptoms and a re-emergence of mental health symptoms during medication cessation. Research into the withdrawal symptoms of antipsychotic medications has expanded in recent years, although scientific literature about aripiprazole withdrawal symptoms specifically is still limited.

Common Abilify withdrawal symptoms

Aripiprazole withdrawal symptoms can include psychological, physical, and movement-related symptoms.

Psychological symptoms

Psychological symptoms that could occur during Abilify withdrawal can include:

Physical symptoms

Physical symptoms that could occur during Abilify withdrawal can include:

  • Nausea 
  • Headaches
  • Lightheadedness or dizziness
  • Tremors and shaking
  • Flu-like symptoms
  • Tachycardia
  • Sweating 
  • Restlessness 
  • Loss of appetite 

Movement-related symptoms that could occur during Abilify withdrawal can include:

  • Abnormal or unusual movements in the jaw, tongue, or hands
  • Twitches
  • Akathisia or restless leg syndrome (RLS)
  • Neuroleptic malignant syndrome (NMS)

Distinguishing withdrawal, relapse, and rebound

It can be difficult to differentiate between withdrawal, relapse, and rebound symptoms when discontinuing a medication. These terms refer to:

  • Withdrawal: New symptoms that occur quickly after discontinuation or a dose decrease.
  • Relapse: Symptoms of the original condition that return after the medication is stopped.
  • Rebound: Symptoms of the original condition that return after discontinuation but are more severe than they were prior to treatment.

Withdrawal symptoms can be similar to rebound symptoms in that they tend to last a short time and alleviate on their own. However, the difference is that withdrawal symptoms often involve a new set of symptoms, while rebound symptoms are similar to those that occurred before treatment, albeit in greater severity.

Relapse can be differentiated from withdrawal by the time of onset. Withdrawal occurs within the first couple of days of cessation and abates within a matter of weeks. Relapse, however, may involve a gradual return of symptoms, distributed over time.

People may be at risk of relapse after aripiprazole discontinuation for 1-3 years, and the onset of severe withdrawal symptoms might increase their vulnerability.

Timeline: How long do Abilify withdrawal symptoms last?

When Abilify is stopped, withdrawal symptoms are likely to emerge within 2-3 days. They can be at their most severe within the first two weeks, after which, they typically will reduce gradually on their own.

In some cases, withdrawal symptoms can be more severe and may last longer, which might require professional intervention to manage. Research suggests that antipsychotic withdrawals can be long-lasting, sometimes lasting months or even years after the medication is stopped. The timeline and severity of withdrawals vary depending on a number of factors, including the dose and length of time the medication was used.

Risks of stopping Abilify suddenly

Stopping aripiprazole abruptly can significantly increase the risk and severity of withdrawal symptoms. It can also be dangerous, as mental health symptoms can re-emerge if they are not being managed effectively. It is recommended to reduce the dose of Abilify gradually and to utilize professional guidance throughout the cessation process.

Risk factors and who faces severe symptoms

Risk factors that can be associated with a higher likelihood of experiencing withdrawal symptoms or a greater risk of severe symptoms can include:

  • Abrupt discontinuation.
  • Gender and age might influence the likelihood of withdrawal symptoms, with potentially higher risks among females and older adults.
  • Longer treatment duration and higher dosage can increase the risk of withdrawal symptoms.
  • Concurrent use of other mood or mind-altering drugs, including prescribed mental health medications.
  • History and severity of mental health symptoms.

Tapering schedules and medical management

When coming off aripiprazole, it is advised to make gradual dose reductions under the close supervision of a doctor or prescribing professional. A tapering schedule might depend on the individual, the duration and amount of their treatment, and their response to dose reductions. 

Generally, it is recommended to commence aripiprazole tapering slowly, to give time for the body to make the necessary neurological and biological adaptations and to recognize and manage any severe withdrawal symptoms that occur. Slow dose reductions can help prevent the onset of withdrawal symptoms and reduce the risk of rebound symptoms.

An example of an aripiprazole tapering schedule might involve making a 10% dose reduction every 2-4 weeks.

If withdrawal symptoms occur, they can be managed with professional support, such as medications like benzodiazepines and anticholinergics. They might also be manageable with lifestyle changes and improvements in diet and exercise. If withdrawal symptoms are severe or problematic, the dose can be increased slightly, followed by a slower and more gradual taper.

Tapering can be paused or slowed as required. It can be beneficial to prolong this process to last for several months, particularly among those who have used high doses for many years, to help prevent withdrawal symptoms. 

When to seek medical help

Always seek professional advice before changing the dosage of aripiprazole. Never skip or reduce doses unless instructed by a medical professional. With professional guidance, aripiprazole can be reduced, and the individual will receive regular reviews and symptom monitoring to ensure their safety.

During this process, if concerning or severe withdrawal symptoms emerge, contact the prescribing physician immediately. It may be necessary to pause or reverse dose reductions, or additional medications and support might be required to help manage withdrawal symptoms.

Was this page helpful?

Your feedback allows us to continually improve our information

Resources:

  1. Gettu, N., & Saadabadi, A. (Updated 2023). Aripiprazole. In: StatPearls [Internet]. Treasure Island, FL: StatPearls Publishing. Retrieved from
  2. Sansone, R.A., & Sawyer, R.J. (2013). Aripiprazole Withdrawal: A Case Report. Innovations in Clinical Neuroscience, 10(5-6), 10–12. Retrieved from
  3. Read, J. (2022). The Experiences of 585 People When They Tried to Withdraw from Antipsychotic Drugs. Addictive Behaviors Reports, 15, 100421. Retrieved from
  4. Brandt, L., Bschor, T., Henssler, J., Müller, M., Hasan, A., Heinz, A., & Gutwinski, S. (2020). Antipsychotic Withdrawal Symptoms: A Systematic Review and Meta-Analysis. Frontiers in Psychiatry, 11, 569912. Retrieved from
  5. Gali, F., Saleem, R., Maazmi, B., Shukur, M., & Ibrahim, M. (2025) Restless Leg Syndrome Following Aripiprazole Discontinuation: A Case Report. Case Reports in Clinical Medicine, 14(3), 176-181. Retrieved from
  6. Lerner, A., & Klein, M. (2019). Dependence, Withdrawal and Rebound of CNS Drugs: an Update and Regulatory Considerations for New Drugs Development. Brain Communications, 1(1), fcz025. Retrieved from
  7. Horowitz, M.A., Jauhar, S., Natesan, S., Murray, R.M., & Taylor, D. (2021). A Method for Tapering Antipsychotic Treatment That May Minimize the Risk of Relapse. Schizophrenia Bulletin, 47(4), 1116–1129. Retrieved from
  8. Cerovecki, A., Musil, R., Klimke, A., Seemüller, F., Haen, E., Schennach, R., Kühn, K.U., Volz, H.P., & Riedel, M. (2013). Withdrawal Symptoms and Rebound Syndromes Associated with Switching and Discontinuing Atypical Antipsychotics: Theoretical Background and Practical Recommendations. CNS Drugs, 27(7), 545–572. Retrieved from

Activity History - Last updated: 08 March 2026, Published date:


Reviewer

Hailey Okamoto

M.Ed, LCMHCS, LCAS, CCS

Hailey Okamoto is a Licensed Clinical Mental Health Counselor, Licensed Clinical Addiction Specialist, and Certified Clinical Supervisor with extensive experience in counseling people with mental health and addictive disorders.

Activity History - Medically Reviewed on 04 March 2026 and last checked on 08 March 2026

Medically reviewed by
Hailey Okamoto

Hailey Okamoto

M.Ed, LCMHCS, LCAS, CCS

Reviewer

Recovered Branding BG
Ready to talk about treatment? Call today. (833) 840-1202
Helpline Information

Calls to numbers marked with (I) symbols will be answered or returned by one of the treatment providers listed in our Terms and Conditions, each of which is a paid advertiser.

In calling the helpline you agree to our Terms and Conditions. We do not receive any fee or commission dependent upon which treatment or provider a caller chooses.

There is no obligation to enter treatment.

Access State-Specific Provider Directories for detailed information on locating licensed service providers and recovery residences in your area.

For any specific questions please email us at info@recovered.org

More like this

Withdrawal Symptoms

9 minutes read